SCHEMBL7169342

SCHEMBL7169342

Cc1ccc(S(=O)(=O)N(C)CC(=O)NC(C)Cc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
TAS2R14 Q9NYV8 3/20 0.50
GAA P10253 2/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
ACACB O00763 1/20 0.46
PTGES O14684 1/20 0.45
ALOX5 P09917 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319084 0.80 TDP1 (0.51) TDP1LMNAKDM4EHSD17B10SMN1; SMN2
SCHEMBL30699961 0.78 CA1 (0.54) TDP1GAALMNAKDM4EHSD17B10
SCHEMBL5572753 0.77 SMN1; SMN2 (0.55) LMNAKDM4EHSD17B10SMN1; SMN2RAB9A
SCHEMBL5573302 0.77 KMT2A (0.47) TDP1GAALMNAKDM4EHSD17B10
SCHEMBL5496683 0.75 LMNA (0.61) TDP1GAALMNAKDM4EHSD17B10
SCHEMBL5496678 0.75 LMNA (0.61) TDP1GAALMNAKDM4EHSD17B10
SCHEMBL5569684 0.74 STAT3 (0.50) TDP1TAS2R14LMNAKDM4EHSD17B10
SCHEMBL4325972 0.73 ACACB (0.66) TDP1LMNASMN1; SMN2RAB9AKMT2A
SCHEMBL5573170 0.73 TACR1 (0.54) LMNAKDM4EHSD17B10SMN1; SMN2RAB9A
SCHEMBL3858034 0.73 MAPK1 (0.48) TDP1LMNAKDM4EHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559127-B1 Intercellular adhesion mediated by VLA-4 and other cell surface receptors is associated with a number of inflammatory responses ATHENA NEUROSCIENCES, INC. 2003-05-06 US disclosed